I wish you are right. I am not selling as I still think one day this could surprise us. It’s been a bad stock and I’m well down with the reverse split , but at this stage I will just wait and see. Do we dilute again and split again or was this done with the intention of finding a suitor for the small float available. Who knows . The company could be bought for a pittance and all research started again in phase 3. Not a bad deal for a very promising cancer drug